| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/21/2008 | US20080044417 Cancer, autoimmune and inflammatory disease, vaccines; binds to the extracellular domain of native human Fc gamma RIIB with greater affinity than to the extracellular domain of native human Fc gamma RIIA |
| 02/21/2008 | US20080044416 Novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer |
| 02/21/2008 | US20080044414 IL-1beta binding antibodies and fragments thereof |
| 02/21/2008 | US20080044413 EphA2 BiTE molecules and uses thereof |
| 02/21/2008 | US20080044409 Inflammatory mediator antagonists |
| 02/21/2008 | US20080044406 Neuroactive fragments of APP |
| 02/21/2008 | US20080044403 Immune Markers Used for Diagnosis and Therapy in Connection With Transplant Reactions |
| 02/21/2008 | US20080044396 Method of Raising Livestock |
| 02/21/2008 | US20080044393 Retinal dystrophin transgene and methods of use thereof |
| 02/21/2008 | US20080044392 Isolation of Stem Cell-Like Cells and Use Thereof |
| 02/21/2008 | US20080044388 Method for Production of Arachidonic Acid |
| 02/21/2008 | US20080044387 Artificial niches for enhancement of regenerative capacity of stem cells in aged and pathological environments |
| 02/21/2008 | US20080044385 Novel Modified Galectin 8 Proteins and Use Thereof |
| 02/21/2008 | US20080044384 Recombinant Human Cytomegalovirus And Vaccines Comprising Heterologous Antigens |
| 02/21/2008 | US20080044378 Methods and Compositions for Protein Production Using Adenoviral Vectors |
| 02/21/2008 | US20080044363 Therapeutic Dental Composition |
| 02/21/2008 | US20080044359 Cell permeable probe |
| 02/21/2008 | CA2660903A1 Modulators of muscarinic receptors |
| 02/21/2008 | CA2660902A1 Methods for reducing toxicities associated with medical procedures employing radiographic contrast agents |
| 02/21/2008 | CA2659267A1 Influenza hemagglutinin and neuraminidase variants |
| 02/21/2008 | CA2658050A1 Diagnosis and treatment of cancer using anti-desmoglein 3 antibodies |
| 02/20/2008 | EP1889915A1 APO-2 ligand |
| 02/20/2008 | EP1889848A1 6,7-unsaturated-7-carbamoyl substituted morphinan derivative |
| 02/20/2008 | EP1889842A1 Heterocyclic compound |
| 02/20/2008 | EP1889839A1 Bicyclic compound, production and use as HIV inhibitors |
| 02/20/2008 | EP1889838A1 Thrombopoietin mimetics |
| 02/20/2008 | EP1889836A1 Novel pyridine derivative and pyrimidine derivative (3) |
| 02/20/2008 | EP1889639A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents, for producing long lasting antineoplastic agents |
| 02/20/2008 | EP1889623A2 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 02/20/2008 | EP1889618A1 Combined drug for treating diabetes |
| 02/20/2008 | EP1889615A2 Formulations for oral administration with a health promoting effect on the osteoarticular and muscleskeleton apparatus |
| 02/20/2008 | EP1889614A2 Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction |
| 02/20/2008 | EP1889609A2 Immune response modifier foam formulations |
| 02/20/2008 | EP1888559A2 Piperazine-piperidine antagonists and agonists of the 5-ht1a receptor |
| 02/20/2008 | EP1888060A2 Nk-b inhibitors for the treatment of muscular dystrophy |
| 02/20/2008 | EP1888000A2 Method to predict and prevent oxygen-induced inflammatory tissue injury |
| 02/20/2008 | EP1556384B1 Pyrimido compounds having antiproliferative activity |
| 02/20/2008 | EP1443964B1 Photodynamic therapy for the treatment of hair loss |
| 02/20/2008 | EP1436271B1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 02/20/2008 | EP1432417B1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 02/20/2008 | EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/20/2008 | EP1404704B9 Bridged bicyclic serine protease inhibitors |
| 02/20/2008 | EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 02/20/2008 | EP1354871B1 Biphenyl derivatives |
| 02/20/2008 | EP1175411B1 Cyclothiocarbamate derivatives as progesterone receptor modulators |
| 02/20/2008 | EP1131290B1 Piperidine ccr-3 receptor antagonists |
| 02/20/2008 | EP1064010B1 Peptide compositions and formulations and use of same |
| 02/20/2008 | EP1007672B1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways |
| 02/20/2008 | EP0975347B1 Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
| 02/20/2008 | EP0951281B9 2-CYCLOPENTEN-1-ONE AND ITS DERIVATIVES AS INHIBITORS OF THE NF-kappa B FACTOR |
| 02/20/2008 | EP0768890B1 Methods for modulating t cell responses by manipulating a common cytokine receptor gamma chain |
| 02/20/2008 | EP0644877B1 Substituted-hexahydrobenzo a phenanthridines |
| 02/20/2008 | CN101128578A Method of inducing differentiation of skeletal muscle cell |
| 02/20/2008 | CN101128213A Promoter of regeneration of pancreatic beta cell, and promoter of insulin production in pancreatic beta cell |
| 02/20/2008 | CN101125168A New use of wrinkled glanthyssop vital energy preparation |
| 02/20/2008 | CN101124978A Litsea lam season oil and preparation method thereof and application of letsea lam volatile oil in season oil |
| 02/20/2008 | CN100369925C Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 02/20/2008 | CN100369919C Tricyclic protein kinase inhibitors |
| 02/20/2008 | CN100369917C Himbacine analogues as thrombin receptor antagonists |
| 02/20/2008 | CN100369916C 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
| 02/20/2008 | CN100369912C Heteroaryl substituted fused bicyclic heteroaryl compounds as GABAA receptor ligands |
| 02/20/2008 | CN100369906C Method for producing 3-amidinophenylalanine derivatives |
| 02/20/2008 | CN100369904C 2-(replace- amino)-NOBS HIV prolease inhibitor |
| 02/20/2008 | CN100369899C Substituted indazoles with anti-cancer activity |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369894C Nitric oxide synthase inhibitor phosphate salt |
| 02/20/2008 | CN100369891C HIF hydroxylase inhibitors |
| 02/20/2008 | CN100369613C Composition for treating and improving chronic fatigue syndrome and its preparing method |
| 02/19/2008 | US7332644 Screening for a developmental promoter or a developmental suppressor of oligodendrocytes, or a promoter or a suppressor of myelinogenesis, diagnostic for neuropsychiatric disorders |
| 02/19/2008 | US7332610 Chemical intermediates for production of sibutramine |
| 02/19/2008 | US7332586 Active agent and a nuclear localization signal and methods of modulating gene expression and protein expression employing the nanoparticle delivery vehicle. A representative method includes providing a nanoparticle delivery vehicle comprising |
| 02/19/2008 | US7332515 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 02/19/2008 | US7332514 Dibenzylamine compound and medicinal use thereof |
| 02/19/2008 | US7332507 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 02/19/2008 | US7332498 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 02/19/2008 | US7332497 Pyrazolopyrimidines as therapeutic agents |
| 02/19/2008 | US7332496 Methods of using sodium channel blockers |
| 02/19/2008 | US7332493 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
| 02/19/2008 | US7332487 Nitrogen-containing 5-membered ring compound |
| 02/19/2008 | US7332486 9-(4-carboxyphenyl)-6-cyclopropylamino-2-trifluoromethylpurine; side effect reduction; cognition activator, antidepressants, neuroleptic agent, schizophrenia, Alzheimer's disease, schizophrenia, Parkinson's, Huntington's, Pick's, Creutzfeld-Jakob, cardiovascular diseases, HIV |
| 02/19/2008 | US7332484 2,4-pyrimidinediamine compounds and their uses |
| 02/19/2008 | US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease |
| 02/19/2008 | US7332481 Thrombopoietin mimetics |
| 02/19/2008 | US7332185 Component I selected from alpha acids and beta acids and component II selected from alpha acids, beta acids, essential oils, fats and waxes; specific inhibition of cyclooxygenase-2 with little effect on cyclooxygenase-1 |
| 02/19/2008 | US7332163 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 02/19/2008 | CA2481723C 5ht2c receptor modulators |
| 02/19/2008 | CA2468435C Process for the production of an immunosuppressant |
| 02/19/2008 | CA2431565C Pharmaceutical compositions based on anticholinergics and ciclesonide |
| 02/19/2008 | CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/19/2008 | CA2273848C Mycobacterium vaccae for down-regulation of the th2 activity of the immune system |
| 02/19/2008 | CA2237023C Improved formulation for administration of steroid compounds |
| 02/19/2008 | CA2226582C Non-allosteric gabaa agonists for treating sleep disorders |
| 02/19/2008 | CA2220505C N,o-carboxymethylchitosan for prevention of surgical adhesions |
| 02/19/2008 | CA2209858C Il-2r-associated polypeptide and dna molecules coding therefor |
| 02/19/2008 | CA2206366C Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 02/19/2008 | CA2197210C Intravenous alendronate formulations |
| 02/19/2008 | CA2173976C Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 02/19/2008 | CA2113726C Use of tetrahydrocarbazone derivatives as 5ht1 receptor agonists |
| 02/19/2008 | CA1341567C Dna sequences, recombinant dna molecules and processes for producing human interferon - like polypeptides |
| 02/14/2008 | WO2008019052A2 Methods and compositions for identifying biomarkers |